PRV211

· Privo Technologies

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRV211, covering 2026-04-23 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers [Phase 2, Phase 3]

See pricing